08/14/2024
2:12 PM | Amneal Pharmaceuticals (Subject)
Shah Nikita (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2024
10:04 AM | Amneal Pharmaceuticals (Subject)
Shah Nikita (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2024
3:27 PM | Amneal Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2024
5:14 AM | Amneal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2024
2:13 PM | Amneal Pharmaceuticals (Subject)
Autor Deborah M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/14/2024
3:38 PM | Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
3:39 PM | Amneal Pharmaceuticals (Issuer)
Yanai Shlomo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
05/14/2024
3:40 PM | Amneal Pharmaceuticals (Issuer)
Nark Ted C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
3:41 PM | Amneal Pharmaceuticals (Issuer)
BUCHI J KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
3:42 PM | Amneal Pharmaceuticals (Issuer)
George Jeffrey P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
3:43 PM | Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
3:44 PM | Amneal Pharmaceuticals (Issuer)
MEISTER PAUL M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
3:45 PM | Amneal Pharmaceuticals (Issuer)
Autor Deborah M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
3:45 PM | Alva Emily Peterson (Reporting)
Amneal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
3:46 PM | Amneal Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
3:18 PM | Amneal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
4:19 PM | Amneal Pharmaceuticals (Issuer)
Autor Deborah M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
4:23 PM | Amneal Pharmaceuticals (Issuer)
BUCHI J KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
4:28 PM | Amneal Pharmaceuticals (Issuer)
George Jeffrey P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
4:31 PM | Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
4:34 PM | Amneal Pharmaceuticals (Issuer)
Nark Ted C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
4:35 PM | Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
4:38 PM | Amneal Pharmaceuticals (Issuer)
Yanai Shlomo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
5:14 AM | Amneal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
5:03 AM | Amneal Pharmaceuticals (Subject)
Fosun International Ltd (Filed by)
| Form SC 13G/A | |
03/22/2024
7:01 AM | Amneal Pharmaceuticals (Filer)
| Form DEF 14A | |
03/22/2024
7:01 AM | Amneal Pharmaceuticals (Filer)
| Form DEFA14A | |
03/14/2024
4:04 PM | Amneal Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/06/2024
4:39 PM | Amneal Pharmaceuticals (Issuer)
Patel Chirag K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:40 PM | Amneal Pharmaceuticals (Issuer)
Patel Chintu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:54 PM | Amneal Pharmaceuticals (Issuer)
Daly Jason B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:40 PM | Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
5:13 AM | Amneal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2024
6:03 AM | Amneal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
3:09 PM | Amneal Pharmaceuticals (Subject)
Mahesh Akram (Filed by)
| Form SC 13G | |
01/03/2024
3:30 PM | Amneal Pharmaceuticals (Subject)
Patel Gautam (Filed by)
| Form SC 13D/A | |
12/26/2023
6:06 PM | Amneal Pharmaceuticals (Filer)
| Form CERT | |
12/26/2023
3:10 PM | Amneal Pharmaceuticals (Filer)
| Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities | |
12/12/2023
5:04 AM | Amneal Pharmaceuticals (Subject)
Fosun International Ltd (Filed by)
| Form SC 13G/A | |
11/20/2023
5:07 AM | Amneal Pharmaceuticals (Filer)
| Form 15-12G | |
11/14/2023
11:15 PM | Amneal Pharmaceuticals (Filer)
| Form EFFECT | |
NASDAQ to crash 50%? (Ad) During the 2020 Covid Crash he called a market reversal - eleven days before the S&P bottomed out...
Now, he's saying there are four major cracks forming in the US economy... Click here to learn more >>> |
11/14/2023
11:15 PM | Amneal Pharmaceuticals (Filer)
| Form EFFECT | |
11/08/2023
5:20 PM | Amneal Pharmaceuticals (Issuer)
Patel Chirag K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
5:21 PM | Amneal Pharmaceuticals (Issuer)
Patel Dipan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
5:21 PM | Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
5:22 PM | Amneal Pharmaceuticals (Issuer)
Patel Tushar Bhikhubhai (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
5:20 PM | Amneal Pharmaceuticals (Issuer)
Patel Chintu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
4:03 PM | Amneal Pharmaceuticals (Subject)
Patel Gautam (Filed by)
| Form SC 13D/A | |
11/08/2023
4:05 PM | Amneal Pharmaceuticals (Subject)
Patel Dipan (Filed by)
| Form SC 13D/A | |
11/08/2023
4:07 PM | Amneal Pharmaceuticals (Subject)
Patel Chirag K. (Filed by)
| Form SC 13D/A | |
11/08/2023
4:12 PM | Amneal Pharmaceuticals (Filer)
| Form POS AM | |
11/08/2023
4:13 PM | Amneal Pharmaceuticals (Filer)
| Form POS AM | |
11/08/2023
4:13 PM | Amneal Pharmaceuticals (Filer)
| Form S-8 POS | |
11/08/2023
4:14 PM | Amneal Pharmaceuticals (Filer)
| Form S-8 POS | |
11/08/2023
4:15 PM | Amneal Pharmaceuticals (Filer)
| Form S-8 POS | |
11/08/2023
8:36 AM | Amneal Pharmaceuticals (Subject)
NEW YORK STOCK EXCHANGE LLC (Filed by)
| Form 25-NSE | |
11/08/2023
6:40 AM | Amneal Pharmaceuticals (Filer)
| Form 8-K12B | |
11/07/2023
5:21 AM | Amneal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2023
3:16 PM | Amneal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2023
5:51 AM | Amneal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
